Open Access

Transcriptomic model‑based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma

  • Authors:
    • Zhi‑Li Zhang
    • Li‑Jing Zhao
    • Lin Xu
    • Liang Chai
    • Feng Wang
    • Ya‑Ping Xu
    • Shui‑Hong Zhou
    • Yong Fu
  • View Affiliations

  • Published online on: April 4, 2019     https://doi.org/10.3892/ol.2019.10213
  • Pages: 5536-5544
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Head and neck squamous cell carcinoma (HNSC) is one of most common types of cancer worldwide, and mRNAs and long non‑coding RNAs (lncRNAs) have been identified as prognostic biomarkers in HNSC. In the present study, using gene expression datasets from multiple platforms, survival‑associated genes in HNSC were identified. Subsequently, a combination of 17 genes (14 mRNAs and 3 lncRNA) was optimized using random forest variable hunting and a risk score model for HNSC prognosis was developed using a cohort from The Cancer Genome Atlas. Patients with high‑risk scores tend to have earlier disease recurrence and lower survival rates, compared with those with low‑risk scores. This observation was further validated in three independent datasets (GSE41613, GSE10300 and E‑MTAB‑302). Association analysis revealed that the risk score is independent of other clinicopathological observations. On the basis of the results depicted in the nomogram, the risk score performs better in 3‑year survival rate prediction than other clinical observations. In summary, the lncRNA‑mRNA signature‑based risk score successfully predicts the survival of HNSC and serves as an indicator of prognosis.

References

1 

Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Katiyar SK: Emerging phytochemicals for the prevention and treatment of head and neck cancer. Molecules. 21(pii): E16102016. View Article : Google Scholar : PubMed/NCBI

4 

de Andrade DA and Machiels JP: Treatment options for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, who progress after platinum-based chemotherapy. Curr Opin Oncol. 24:211–217. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, et al: Head and neck cancers. J Natl Compr Canc Netw. 9:596–650. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Song W and Zou SB: Prognostic role of lncRNA HOTAIR in esophageal squamous cell carcinoma. Clin Chim Acta. 463:169–173. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Chen Z, He A, Wang D, Liu Y and Huang W: Long noncoding RNA HOTTIP as a novel predictor of lymph node metastasis and survival in human cancer: A systematic review and meta-analysis. Oncotarget. 8:14126–14132. 2017.PubMed/NCBI

8 

He A, Hu R, Chen Z, Liao X, Li J, Wang D, Lv Z, Liu Y, Wang F and Mei H: Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: A meta-analysis. Oncotarget. 8:1937–1943. 2017.PubMed/NCBI

9 

Chen J, Miao Z, Xue B, Shan Y, Weng G and Shen B: Long non-coding RNAs in urologic malignancies: Functional roles and clinical translation. J Cancer. 7:1842–1855. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Nohata N, Abba MC and Gutkind JS: Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection. Oral Oncol. 59:58–66. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Zou AE, Ku J, Honda TK, Yu V, Kuo SZ, Zheng H, Xuan Y, Saad MA, Hinton A, Brumund KT, et al: Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. RNA. 21:1122–1134. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Denaro N, Merlano MC, Russi EG and Lo Nigro C: Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): A clinical perspective. Anticancer Res. 34:6887–6896. 2014.PubMed/NCBI

13 

Xu CZ, Jiang C, Wu Q, Liu L, Yan X and Shi R: A feed-forward regulatory loop between HuR and the long noncoding RNA HOTAIR promotes head and neck squamous cell carcinoma progression and metastasis. Cell Physiol Biochem. 40:1039–1051. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, et al: The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget. 7:51211–51222. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Tian X and Xu G: Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: Systematic review and meta-analysis. BMJ Open. 5:e0086532015. View Article : Google Scholar : PubMed/NCBI

16 

Jadaliha M, Zong X, Malakar P, Ray T, Singh DK, Freier SM, Jensen T, Prasanth SG, Karni R, Ray PS and Prasanth KV: Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget. 7:40418–40436. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Huang C, Yu Z, Yang H and Lin Y: Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients. Biomed Pharmacother. 83:8–13. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Kong L, Zhou X, Wu Y, Wang Y, Chen L, Li P, Liu S, Sun S, Ren Y, Mei M, et al: Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo. Curr Mol Med. 15:952–960. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Fayda M, Isin M, Tambas M, Guveli M, Meral R, Altun M, Sahin D, Ozkan G, Sanli Y, Isin H, et al: Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumour Biol. 37:3969–3978. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Chen H, Xin Y, Zhou L, Huang JM, Tao L, Cheng L and Tian J: Cisplatin and paclitaxel target significant long noncoding RNAs in laryngeal squamous cell carcinoma. Med Oncol. 31:2462014. View Article : Google Scholar : PubMed/NCBI

21 

Lohavanichbutr P, Méndez E, Holsinger FC, Rue TC, Zhang Y, Houck J, Upton MP, Futran N, Schwartz SM, Wang P and Chen C: A 13-gene signature prognostic of HPV-negative OSCC: Discovery and external validation. Clin Cancer Res. 19:1197–1203. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH and Rosner MR: A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res. 69:65–74. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Tang Y, Xiang W, Terry L, Kretzschmar HA and Windl O: Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy. PLoS One. 5:e142072010. View Article : Google Scholar : PubMed/NCBI

24 

Zhang ZL, Zhao LJ, Chai L, Zhou SH, Wang F, Wei Y, Xu YP and Zhao P: Seven lncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma. Sci Rep. 7:3092017. View Article : Google Scholar : PubMed/NCBI

25 

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC and Müller M: pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 12:772011. View Article : Google Scholar : PubMed/NCBI

26 

Liu Q, Diao R, Feng G, Mu X and Li A: Risk score based on three mRNA expression predicts the survival of bladder cancer. Oncotarget. 8:61583–61591. 2017.PubMed/NCBI

27 

Sawabe M, Ito H, Oze I, Hosono S, Kawakita D, Tanaka H, Hasegawa Y, Murakami S and Matsuo K: Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: A prospective study. Cancer Sci. 108:91–100. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Bou Samra E, Klein B, Commes T and Moreaux J: Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients. Oncotarget. 3:824–832. 2012.PubMed/NCBI

29 

Kim SK, Kim SY, Kim JH, Roh SA, Cho DH, Kim YS and Kim JC: A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients. Mol Oncol. 8:1653–1666. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Bou Samra E, Klein B, Commes T and Moreaux J: Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients. Biomed Res Int. 2014:4231742014. View Article : Google Scholar : PubMed/NCBI

31 

Massari F, Bria E, Ciccarese C, Munari E, Modena A, Zambonin V, Sperduti I, Artibani W, Cheng L, Martignoni G, et al: Prognostic value of beta-tubulin-3 and c-Myc in muscle invasive urothelial carcinoma of the bladder. PLoS One. 10:e01279082015. View Article : Google Scholar : PubMed/NCBI

32 

Schmitt AM and Chang HY: Long noncoding RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Weng M, Wu D, Yang C, Peng H, Wang G, Wang T and Li X: Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Transl Res. 181:108–120. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, Z., Zhao, L., Xu, L., Chai, L., Wang, F., Xu, Y. ... Fu, Y. (2019). Transcriptomic model‑based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma. Oncology Letters, 17, 5536-5544. https://doi.org/10.3892/ol.2019.10213
MLA
Zhang, Z., Zhao, L., Xu, L., Chai, L., Wang, F., Xu, Y., Zhou, S., Fu, Y."Transcriptomic model‑based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma". Oncology Letters 17.6 (2019): 5536-5544.
Chicago
Zhang, Z., Zhao, L., Xu, L., Chai, L., Wang, F., Xu, Y., Zhou, S., Fu, Y."Transcriptomic model‑based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma". Oncology Letters 17, no. 6 (2019): 5536-5544. https://doi.org/10.3892/ol.2019.10213